Quote:
Originally Posted by lkagele
Not sure I really agree. Your theory might make sense with a business that produces products. TVH, however, provides services and the capital outlay to expand a service business is much less than is needed to expand manufacturing capabilities. The listed assets certainly don't indicate those overpayments went to purchase tangible assets.
Pfizer sold $100 billion in vaccines yet its stock went from the low 30's to the low 20's. So, just like Pfizer's profits, I think this overpayment money went somewhere it should not have.
|
Maybe, maybe not. I'm sure TVH will get to "entertain" an army of forensic accountants.